DataSheet_1_Comparison of Clinical Characteristics Among COVID-19 and Non-COVID-19 Pediatric Pneumonias: A Multicenter Cross-Sectional Study.docx
The pandemic of Coronavirus Disease 2019 (COVID-19) brings new challenges for pediatricians, especially in the differentiation with non-COVID-19 pneumonia in the peak season of pneumonia. We aimed to compare the clinical characteristics of pediatric patients with COVID-19 and other respiratory pathogens infected pneumonias.
MethodsWe conducted a multi-center, cross-sectional study of pediatric inpatients in China. Based on pathogenic test results, pediatric patients were divided into three groups, including COVID-19 pneumonia group, Non-COVID-19 viral (NCV) pneumonia group and Non-viral (NV) pneumonia group. Their clinical characteristics were compared by Kruskal-Wallis H test or chi-square test.
ResultsA total of 636 pediatric pneumonia inpatients, among which 87 in COVID-19 group, 194 in NCV group, and 355 in NV group, were included in analysis. Compared with NCV and NV patients, COVID-19 patients were older (median age 6.33, IQR 2.00-12.00 years), and relatively fewer COVID-19 patients presented fever (63.2%), cough (60.9%), shortness of breath (1.1%), and abnormal pulmonary auscultation (18.4%). The results were verified by the comparison of COVID-19, respiratory syncytial virus (RSV) and influenza A (IFA) pneumonia patients. Approximately 42.5%, 44.8%, and 12.6% of the COVID-19 patients presented simply ground-glass opacity (GGO), simply consolidation, and the both changes on computed tomography (CT) scans, respectively; the proportions were similar as those in NCV and NV group (p>0.05). Only 47.1% of COVID-19 patients had both lungs pneumonia, which was significantly lower than that proportion of nearly 80% in the other two groups. COVID-19 patients presented lower proportions of increased white blood cell count (16.5%) and abnormal procalcitonin (PCT) (10.7%), and a higher proportion of decreased lymphocyte count (44.0%) compared with the other two groups.
ConclusionMajority clinical characteristics of pediatric COVID-19 pneumonia patients were milder than non-COVID-19 patients. However, lymphocytopenia remained a prominent feature of COVID-19 pediatric pneumonia.
History
References
- https://doi.org//10.1016/S1473-3099%2820%2930396-0
- https://doi.org//10.15585/mmwr.mm6914e4
- https://doi.org//10.1002/jmv.25810
- https://doi.org//10.1183/13993003.00749-2020
- https://doi.org//10.1371/journal.pone.0236312
- https://doi.org//10.1056/NEJMoa2021680
- https://doi.org//10.1056/NEJMoa2002032
- https://doi.org//10.1016/S0140-6736%2820%2930183-5
- https://doi.org//10.1186/s12967-020-02374-0
- https://doi.org//10.1016/S0140-6736%2816%2931593-8
- https://doi.org//10.1016/j.ijid.2020.06.026
- https://doi.org//10.1111/apa.15270
- https://doi.org//10.1056/NEJMc2005073
- https://doi.org//10.1016/S0140-6736%2820%2930251-8
- https://doi.org//10.1016/j.ultrasmedbio.2020.04.026
- https://doi.org//10.1002/ppul.25255
- https://doi.org//10.1542/peds.2014-2833
- https://doi.org//10.1002/jmv.25807
- https://doi.org//10.1007/s12519-020-00343-7
- https://doi.org//10.1080/22221751.2020.1744483
- https://doi.org//10.1002/ppul.24718
- https://doi.org//10.1001/jamapediatrics.2020.2430
- https://doi.org//10.1164/rccm.202001-0179LE
- https://doi.org//10.1016/j.jinf.2020.04.030
- https://doi.org//10.1056/NEJMoa2001017
- https://doi.org//10.1097/INF.0000000000002660
CC BY 4.0